Organometallics
Article
were commercially available. Solvents were used as received without
purification or drying.
were mixed in CH2Cl2 (10 mL) until a colorless solution formed (5
min). NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture
stirred for 1 h. The solution was filtered through a plug of silica and
the colorless filtrate evaporated to minimum volume. Pentane was
added to precipitate a white solid, which was collected and vacuum-
dried to give the product (0.0718 g, 78%). 1H NMR (300 MHz,
DMSO): δ 8.63 (m, 1H, Py), 8.20 (dd, 3JHH = 7.1, 4JHH = 1.0 Hz, 1H,
Py), 8.17−8.09 (m, 1H, Py), 8.03 (d, 3JHH = 2.1 Hz, 1H, CH), 7.82 (d,
3JHH = 2.1 Hz, 1H, CH), 7.61 (m, 1H, Py), 5.17 (d, 4JHH = 2.5 Hz, 2H,
1,3-Bis(2-propyn-1-yl)-1H-imidazol-3-ium Bromide (c). To a
solution of imidazole (0.2723 g, 4.0 mmol) in acetonitrile (30 mL) was
added propargyl bromide (0.86 mL, 8.0 mmol, 80 wt % solution in
toluene) and the mixture heated to reflux for 24 h. After the mixture
was cooled to room temperature, solvent was removed in vacuo to
leave an oily solid, which was recrystallized in acetonitrile/Et2O,
washed with further Et2O, and vacuum-dried to give the product as a
beige solid (0.2851 g, 32%).
4
CH2), 3.69 (t, JHH = 2.5 Hz, 1H, CCH). 13C APT (75 MHz,
Spectral data are in agreement with those previously reported in the
literature.
DMSO): δ 171.96 (s, N−C−N), 150.28 (s, ipso-Py), 149.17 (s, CH
(Py)), 139.61 (s, CH (Py)), 124.75 (s, CH (Py)), 122.43 (s, CH),
121.50 (s, CH), 118.07 (s, CH (Py)), 77.87 (s, CCH), 77.80 (s,
CCH), 40.91 (s, CH2−CCH).
1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium Bromide (d).
To a solution of 1-pyridylimidazole (0.7259 g, 5.0 mmol) in
acetonitrile (50 mL) was added propargyl bromide (1.1 mL, 10.0
mmol, 80 wt % solution in toluene) and the mixture heated to reflux
for 24 h. A pale yellow precipitate formed, which was collected by
vacuum filtration, washed with Et2O, and vacuum-dried to give the
product (0.9504 g, 72%).
Synthesis of [Au(NHC)2]Br (2). Complex 2a. 1-Methyl-3-(2-
propyn-1-yl)-1H-imidazol-3-ium bromide (0.0804 g, 0.4 mmol) and
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in THF (10 mL) until a
colorless solution formed (5 min). NBu4(acac) (0.1366 g, 0.4 mmol)
was added and the mixture stirred. After approximately 30 min a white
precipitate formed. The mixture was stirred for 12 h and then the
precipitate collected by vacuum filtration and dried to give the product
(0.0848 g, 82%). 1H NMR (300 MHz, DMSO): δ 7.60 (d, 3JHH = 1.8
1H NMR (300 MHz, DMSO): δ 10.20 (s, 1H, N−CH−N,
imidazole), 8.65 (dd, 3JHH = 4.8, 4JHH = 1.0 Hz, 1H, Py), 8.60 (m, 1H,
CH), 8.27−8.18 (m, 1H, Py), 8.16−8.05 (m, 2H, Py and CH), 7.72−
7.60 (m, 1H, Py), 5.35 (d, 4JHH = 2.6 Hz, 2H, CH2), 3.92 (t, 4JHH = 2.6
Hz, 1H, CCH). 13C APT (75 MHz, DMSO): δ 149.25 (s, CH
(Py)), 146.29 (s, ipso-Py), 140.63 (s, CH (Py)), 135.13 (s, N−C−N),
125.39 (s, CH (Py)), 123.38 (s, CH), 119.74 (s, CH), 114.49 (s, CH
(Py)), 79.30 (s, CCH), 75.85 (s, CCH), 39.24 (s, CH2−C
CH).
3
Hz, 1H, CH imidazole), 7.55 (d, JHH = 1.8 Hz, 1H, CH imidazole),
5.13 (d, 4JHH = 2.5 Hz, 2H, CH2), 3.90 (s, 3H, Me), 3.65 (t, 4JHH = 2.5
Hz, 1H, CCH). 13C APT (75 MHz, DMSO): δ 183.28 (s, N−C−
N), 123.51 (s, CH), 122.05 (s, CH), 78.60 (s, CCH), 77.45 (s, C
CH), 39.69 (s, CH2−CCH), 37.75 (s, CH3). HRMS (ESI/QTOF)
m/z: [M]+ calcd for C14H16AuN4 437.1035; found 437.1049.
Synthesis of [AuBr(NHC)] (1). Complex 1a. 1-Methyl-3-(2-
propyn-1-yl)-1H-imidazol-3-ium bromide (0.0402 g, 0.2 mmol) and
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 mL)
until a colorless solution formed (5 min). NBu4(acac) (0.0683 g, 0.2
mmol) was added and the mixture stirred for 1 h. The solution was
filtered through a plug of silica and the colorless filtrate evaporated to
minimum volume. Pentane was added to precipitate a white solid,
which was collected and vacuum-dried to give the product (0.0646 g,
Complex 2b. 1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bro-
mide (0.1109 g, 0.4 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol)
were mixed in CH2Cl2 (10 mL) until a colorless solution formed (5
min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture
stirred for 1 h. The solution was washed with H2O (3 × 25 mL) and
dried over Na2SO4. The solution was evaporated to minimum volume
under reduced pressure and pentane added to precipitate a white solid,
which was collected and vacuum-dried to give the product (0.0803 g,
63%). 1H NMR (300 MHz, DMSO): δ 7.70 (s, 1H, CH), 7.66 (s, 1H,
CH), 7.34 (m, 5H, Ph), 5.44 (s, 2H, CH2-Ph), 5.13 (d, 4JHH = 1.9 Hz,
2H, CH2-CCH), 3.64 (s, 1H, CCH). 13C APT (75 MHz,
DMSO): δ 182.89 (s, N−C−N), 136.68 (s, ipso-Ph), 128.79 (s, m-Ph),
128.15 (s, p-Ph), 127.63 (s, o-Ph), 122.75 (s, CH), 122.49 (s, CH),
78.36 (s, CCH), 77.54 (s, CCH), 53.82 (s, CH2−Ph), 39.96 (s,
CH2−CCH). HRMS (ESI/QTOF) m/z: [M]+ calcd for
C26H24AuN4 589.1661; found 589.1634.
1
3
82%). H NMR (400 MHz, DMSO): δ 7.53 (d, JHH = 1.9 Hz, 1H,
3
4
CH), 7.48 (d, JHH = 1.9 Hz, 1H, CH), 5.00 (d, JHH = 2.5 Hz, 2H,
CH2), 3.76 (s, 3H, CH3), 3.59 (t, JHH = 2.5 Hz, 1H, CCH). 13C
4
APT (75 MHz, DMSO): δ 172.52 (s, N−C−N), 123.16 (s, CH),
121.35 (s, CH), 78.21 (s, CCH), 77.30 (s, CCH), 39.88 (s, CH2)
37.79 (s, CH3).
Complex 1b. 1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bro-
mide (0.0554 g, 0.2 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol)
were mixed in CH2Cl2 (10 mL) until a colorless solution formed (5
min). NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture
stirred for 1 h. The solution was filtered through a plug of silica and
the colorless filtrate evaporated to minimum volume. Pentane was
added to precipitate a white solid, which was collected and vacuum-
dried to give the product (0.0696 g, 74%). 1H NMR (300 MHz,
Complex 2c. 1,3-Bis(2-propyn-1-yl)-1H-imidazol-3-ium bromide
(0.0900 g, 0.4 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol) were
mixed in THF (10 mL) until a colorless solution formed (5 min).
NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred.
After approximately 30 min a white precipitate formed. The mixture
was stirred for 12 h and then the precipitate collected by vacuum
3
3
1
DMSO): δ 7.60 (d, JHH = 2.0 Hz, 1H, CH), 7.57 (d, JHH = 2.0 Hz,
1H, CH), 7.42−7.27 (m, 5H, Ph), 5.36 (s, 2H, CH2−Ph), 5.03 (d,
filtration and dried to give the product (0.1074 g, 95%). H NMR
(300 MHz, DMSO): δ 7.68 (s, 1H, CH), 5.20 (d, 4JHH = 2.5 Hz, 2H,
4JHH = 2.5 Hz, 2H, CH2-CCH), 3.60 (t, JHH = 2.5 Hz, 1H, C
4
4
CH2), 3.66 (t, JHH = 2.5 Hz, 1H, CCH). 13C APT (75 MHz,
CH). 13C APT (75 MHz, DMSO): δ 172.55 (s, N−C−N), 136.44 (s,
ipso-Ph), 128.78 (s, m-Ph), 128.18 (s, p-Ph), 127.65 (s, o-Ph), 122.10
(s, CH), 121.87 (s, CH), 78.02 (s, CCH), 77.39 (s, CCH), 53.85
(s, CH2−Ph), 40.03 (s, CH2−CCH).
DMSO): δ 183.12 (s, N−C−N), 122.32 (s, CH), 78.27 (s, CCH),
77.64 (s, CCH), 40.13 (s, CH2−CCH). HRMS (ESI/QTOF) m/
z: [M]+ calcd for C18H16AuN4 485.1035; found 485.1044.
Complex 2d. 1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bro-
mide (0.1056 g, 0.4 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol)
were mixed in THF (10 mL) until a colorless solution formed (5 min).
NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred.
After approximately 30 min a white precipitate formed. The mixture
was stirred for 12 h and then the precipitate collected by vacuum
Complex 1c. 1,3-Bis(2-propyn-1-yl)-1H-imidazol-3-ium bromide
(0.0450 g, 0.2 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol) were
mixed in CH2Cl2 (10 mL) until a colorless solution formed (5 min).
NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred
for 1 h. The solution was filtered through a plug of silica and the
colorless filtrate evaporated to minimum volume. Pentane was added
to precipitate a white solid, which was collected and vacuum-dried to
1
filtration and dried to give the product (0.1159 g, 90%). H NMR
3
(300 MHz, DMSO): δ 8.54 (m, 1H, Py), 8.15 (d, JHH = 2.0 Hz, 1H,
1
give the product (0.0616 g, 73%). H NMR (300 MHz, CD2Cl2): δ
CH), 8.13 (d, 3JHH = 5.3 Hz, 1H, Py), 8.01 (m, 1H, Py), 7.91 (d, 3JHH
7.29 (s, 2H, CH), 5.04 (d, 4JHH = 2.6 Hz, 4H, CH2), 2.63 (t, 4JHH = 2.6
Hz, 1H, CCH). 13C APT (75 MHz, CD2Cl2): δ 175.44 (s, N−C−
N), 121.09 (s, CH), 76.22 (s, CCH), 41.48 (s, CH2−CCH).
Complex 1d. 1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bro-
mide (0.0528 g, 0.2 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol)
= 2.0 Hz, 1H, CH), 7.59 (m, 1H, Py), 5.27 (d, JHH = 2.4 Hz, 2H,
4
4
CH2), 3.69 (t, JHH = 2.4 Hz, 1H, CCH). 13C APT (75 MHz,
DMSO): δ 181.34 (s, N−C−N), 150.01 (s, ipso-Py), 148.95 (s, CH
(Py)), 139.67 (s, CH (Py)), 124.65 (s, CH (Py)), 123.10 (s, CH),
121.71 (s, CH), 117.53 (s, CH (Py)), 77.96 (s, CCH), 77.83 (s,
F
Organometallics XXXX, XXX, XXX−XXX